Clínica CENDI Endocrinologia e Diabetes

Goiânia 74230-035

2 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension, Kidney Disease, Chronic

Studies at this site

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now